Clancy Paul J
Director at INCY; EVP, Chief Financial Officer at ALEXION PHARMACEUTICALS INC; Executive VP and CFO at BIIB
- Sold, on record
- $51.3M
- Dollars the filings state
- Form 4 sales
- 16
- Latest May 19, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- INCYINCYTE CORPDirector
- ALEXION PHARMACEUTICALS INCEVP, Chief Financial Officer
- BIIBBIOGEN INC.Executive VP and CFO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- BIIB240,040 shares
- INCY15,000 shares
- ALEXION PHARMACEUTICALS INC11,320 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale BIIBUnusualApr 30, 2013 2013
Sold 23,612 shares at $222.75 ($5.3M)
Clancy Paul J, Executive VP and CFO
Sold 76.9% of holdings ($6.8M position)7,087 shares leftFiling
- 2 Form 4 sale BIIBUnusualSep 16, 2013 +139 days
Sold 99,030 shares at $238.27 ($23.6M)
Clancy Paul J, Executive VP and CFO
Sold 93.3% of holdings ($25.3M position)7,087 shares left4.6x usual sizeFiling
- 3 Form 4 sale BIIBUnusualSep 18, 2013 +2 days
Sold 26,785 shares at $245.00 ($6.6M)
Clancy Paul J, Executive VP and CFO
Sold 79.1% of holdings ($8.3M position)7,087 shares left1.2x usual sizeFiling
- 4 Form 4 sale BIIBUnusualMar 13, 2017 +1272 days
Sold 9,891 shares at $291.55 ($2.9M)
Clancy Paul J, Executive VP and CFO
Sold 32.3% of holdings ($8.9M position)20,705 shares leftFirst sale on recordFiling
- 5 Form 4 sale BIIBUnusualApr 25, 2017 +43 days
Sold 9,892 shares at $290.00 ($2.9M)
Clancy Paul J, Executive VP and CFO
Sold 47.8% of holdings ($6M position)10,813 shares leftFiling
- 6 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedFeb 8, 2018 +289 days
Sold 6,079 shares at $116.31 ($707k)
Clancy Paul J, EVP, Chief Financial Officer
Sold 6.4% of holdings ($11.1M position)89,014 shares leftFirst sale on recordFiling
- 7 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedJul 10, 2018 +152 days
Sold 5,241 shares at $131.11 ($687k)
Clancy Paul J, EVP, Chief Financial Officer
Sold 5.3% of holdings ($12.9M position)93,309 shares leftFiling
- 8 Form 4 sale INCYRoutineMay 19, 2026 +2870 days
Sold 15,000 shares at $94.93 ($1.4M)
Clancy Paul J, Director
10b5-1 planSold 38.7% of holdings ($3.7M position)23,741 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2026 | May 21, 2026 | INCY | Director | Form 4 sale | 15,000 | $1.4M | 38.7% | Routine | SEC |
| Jul 10, 2018 | Jul 12, 2018 | ALEXION PHARMACEUTICALS INC | EVP, Chief Financial Officer | Form 4 sale | 5,241 | $687k | 5.3% | Plan not stated | SEC |
| Feb 8, 2018 | Feb 8, 2018 | ALEXION PHARMACEUTICALS INC | EVP, Chief Financial Officer | Form 4 sale | 6,079 | $707k | 6.4% | Plan not stated | SEC |
| Apr 25, 2017 | Apr 27, 2017 | BIIB | Executive VP and CFO | Form 4 sale | 9,892 | $2.9M | 47.8% | Unusual | SEC |
| Mar 13, 2017 | Mar 14, 2017 | BIIB | Executive VP and CFO | Form 4 sale | 9,891 | $2.9M | 32.3% | Unusual | SEC |
| Sep 18, 2013 | Sep 19, 2013 | BIIB | Executive VP and CFO | Form 4 sale | 26,785 | $6.6M | 79.1% | Unusual | SEC |
| Sep 16, 2013 | Sep 18, 2013 | BIIB | Executive VP and CFO | Form 4 sale | 99,030 | $23.6M | 93.3% | Unusual | SEC |
| Apr 30, 2013 | May 1, 2013 | BIIB | Executive VP and CFO | Form 4 sale | 23,612 | $5.3M | 76.9% | Unusual | SEC |
| Feb 1, 2012 | Feb 3, 2012 | BIIB | Executive VP and CFO | Form 4 sale | 21,400 | $2.6M | 50.3% | Unusual | SEC |
| Jan 3, 2012 | Jan 4, 2012 | BIIB | Executive VP and CFO | Form 4 sale | 20,244 | $2.3M | 48.9% | Unusual | SEC |
| Apr 28, 2011 | Apr 29, 2011 | BIIB | Executive VP and CFO | Form 4 sale | 19,716 | $2M | 31.8% | Unusual | SEC |
| Sep 19, 2008 | Sep 23, 2008 | BIIB | Executive VP and CFO | Form 4 sale | 1,553 | $78k | 3.7% | Plan not stated | SEC |
| Aug 8, 2008 | Aug 11, 2008 | BIIB | Executive VP and CFO | Form 4 sale | 568 | $29k | 1.3% | Plan not stated | SEC |
| Jul 1, 2008 | Jul 2, 2008 | BIIB | CFO | Form 4 sale | 4,208 | $236k | 10.1% | Plan not stated | SEC |
| Feb 21, 2008 | Feb 22, 2008 | BIIB | CFO | Form 4 sale | 2,183 | $131k | 4.9% | Plan not stated | SEC |
| Feb 12, 2008 | Feb 14, 2008 | BIIB | CFO | Form 4 sale | 958 | $58k | 3.1% | Plan not stated | SEC |